Opinion|Videos|August 13, 2024
Looking Ahead: Novel Therapies and Future Perspectives in the Treatment of CLL
The panel concludes its discussion with a look to the future of CLL treatment, focusing on emerging novel agents and exciting clinical research.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- Please share your insights on the growing significance of emerging novel agents in relapsed/refractory CLL.
- Which agents are you most excited about?
- How might these agents influence the future treatment landscape for CLL?
Advertisement
Related to this article
CHMP recommends pirtobrutinib for CLL across all treatment lines after phase 3 trials showed strong efficacy and a favorable safety profile.
Advertisement
Advertisement
Trending on OncLive
1
ctDNA MRD Status Predicts OS Benefit With Adjuvant Chemotherapy in Resected CRC Liver Metastases
2
How Bispecific T-Cell Engager Therapy Works and Why HLA Status Is Non-Negotiable
3
FDA Accepts NDA for Varegacestat in Desmoid Tumors
4
Cracking the KRAS Code: How Daraxonrasib Is Reshaping Pancreatic Cancer and Beyond
5